JP2023519744A5 - - Google Patents
Info
- Publication number
- JP2023519744A5 JP2023519744A5 JP2022559816A JP2022559816A JP2023519744A5 JP 2023519744 A5 JP2023519744 A5 JP 2023519744A5 JP 2022559816 A JP2022559816 A JP 2022559816A JP 2022559816 A JP2022559816 A JP 2022559816A JP 2023519744 A5 JP2023519744 A5 JP 2023519744A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- mitochondrial
- disorders
- diseases
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003174P | 2020-03-31 | 2020-03-31 | |
| US63/003,174 | 2020-03-31 | ||
| US202063118569P | 2020-11-25 | 2020-11-25 | |
| US63/118,569 | 2020-11-25 | ||
| PCT/IL2021/050349 WO2021199032A1 (en) | 2020-03-31 | 2021-03-29 | Mitochondrial augmentation therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023519744A JP2023519744A (ja) | 2023-05-12 |
| JP2023519744A5 true JP2023519744A5 (cg-RX-API-DMAC10.html) | 2024-04-09 |
| JP7825866B2 JP7825866B2 (ja) | 2026-03-09 |
Family
ID=77928517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559816A Active JP7825866B2 (ja) | 2020-03-31 | 2021-03-29 | ミトコンドリア増強療法 |
Country Status (12)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12329781B2 (en) | 2018-07-22 | 2025-06-17 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of renal diseases |
| JP7524157B2 (ja) | 2018-07-22 | 2024-07-29 | ミノヴィア セラピューティクス リミテッド | 脳疾患のミトコンドリア増強療法 |
| US12502408B2 (en) | 2018-07-22 | 2025-12-23 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy for primary mitochondrial diseases |
| WO2020021535A1 (en) | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of ocular diseases |
| MX2022012157A (es) | 2020-03-31 | 2023-02-15 | Minovia Therapeutics Ltd | Celulas geneticamente modificadas enriquecidas con mitocondrias y usos de estas. |
| WO2023060212A1 (en) * | 2021-10-06 | 2023-04-13 | Cellvie Inc. | Enhancing adoptive cell transfer by promoting a superior population of adaptive immune cells |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180030413A1 (en) * | 2015-02-26 | 2018-02-01 | Minovia Therapeutics Ltd. | Mammalian cells enriched with functional mitochondria |
| CN110621774A (zh) * | 2016-10-14 | 2019-12-27 | 儿童医疗中心有限公司 | 用于治疗中枢神经系统疾病和病症的组合物和方法 |
| WO2020021537A1 (en) * | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of liver diseases |
| WO2020021541A1 (en) * | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy with stem cells enriched with functional mitochondria |
| EP3823644A4 (en) * | 2018-07-22 | 2022-06-08 | Minovia Therapeutics Ltd. | MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES |
| JP7524157B2 (ja) * | 2018-07-22 | 2024-07-29 | ミノヴィア セラピューティクス リミテッド | 脳疾患のミトコンドリア増強療法 |
| WO2020021539A1 (en) * | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of muscle diseases |
| US12502408B2 (en) * | 2018-07-22 | 2025-12-23 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy for primary mitochondrial diseases |
-
2021
- 2021-03-29 CN CN202180024268.7A patent/CN115427052A/zh active Pending
- 2021-03-29 WO PCT/IL2021/050349 patent/WO2021199032A1/en not_active Ceased
- 2021-03-29 BR BR112022019432A patent/BR112022019432A2/pt not_active Application Discontinuation
- 2021-03-29 US US17/912,022 patent/US20230338427A1/en active Pending
- 2021-03-29 MX MX2022012233A patent/MX2022012233A/es unknown
- 2021-03-29 CA CA3173425A patent/CA3173425A1/en active Pending
- 2021-03-29 IL IL296786A patent/IL296786A/en unknown
- 2021-03-29 EP EP21779142.5A patent/EP4125959A4/en active Pending
- 2021-03-29 AU AU2021248780A patent/AU2021248780A1/en active Pending
- 2021-03-29 JP JP2022559816A patent/JP7825866B2/ja active Active
- 2021-03-29 KR KR1020227033647A patent/KR20220161326A/ko not_active Ceased
-
2022
- 2022-09-29 CO CONC2022/0013978A patent/CO2022013978A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12605410B2 (en) | Mitochondria-enriched genetically engineered cells and uses thereof | |
| US12239672B2 (en) | Mitochondrial augmentation therapy of ocular diseases | |
| Xiao et al. | Neural stem cell-based regenerative approaches for the treatment of multiple sclerosis | |
| US11951135B2 (en) | Mitochondrial augmentation therapy of muscle diseases | |
| JP2019535691A (ja) | 間葉系幹細胞集団、それらの生成物およびそれらの使用 | |
| JP2022519409A5 (cg-RX-API-DMAC10.html) | ||
| JP2021532095A (ja) | 肝臓疾患のミトコンドリア増強療法 | |
| JP2021532091A (ja) | 膵臓疾患のミトコンドリア増強療法 | |
| JP2021532093A (ja) | 脳疾患のミトコンドリア増強療法 | |
| JP7825866B2 (ja) | ミトコンドリア増強療法 | |
| JP2021527397A (ja) | 造血幹細胞を生成するための方法 | |
| US20230220350A1 (en) | Gene-engineered mesenchymal stem cells and applications thereof | |
| BR112020009377A2 (pt) | métodos e composições para reconstituição de medula óssea não mieloablativa | |
| JP7710265B2 (ja) | 酸化ストレス抵抗性を有する間葉系幹細胞、この製造方法および用途 | |
| JPWO2020158924A1 (ja) | 母児間免疫寛容を誘導する方法 | |
| Lian et al. | In vivo therapy of myocardial infarction with mesenchymal stem cells modified with prostaglandin I synthase gene improves cardiac performance in mice | |
| Kerrigan et al. | Stem cell therapy of gliomas | |
| Ichinose et al. | Increased adherence of T cells to human endothelial cells in patients with human T-cell lymphotropic virus type I-associated myelopathy | |
| Guo et al. | Novel insights into the potential applications of stem cells in pulmonary hypertension therapy | |
| KR20230096146A (ko) | E-셀렉틴 리간드의 당조작 | |
| TW202242099A (zh) | 基因工程間充質幹細胞及其應用 | |
| US20050232905A1 (en) | Use of peripheral blood cells for cardiac regeneration | |
| Pedrazzani | MOBILIZATION-BASED CHEMOTHERAPY-FREE ENGRAFTMENT OF GENE EDITED HEMATOPOIETIC STEM CELLS | |
| KR20250125485A (ko) | 배아 줄기세포 유래 중간엽 줄기세포로부터 혈관내피세포를 제조하는 방법 및 제조된 혈관내피세포를 포함하는 심뇌 및 혈관 질환 예방 또는 치료용 조성물 | |
| JP2024546826A (ja) | 骨髄異形成症候群のためのミトコンドリア増強療法 |